3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
51
Fallopian Tube Neoplasms
28
Ovarian Neoplasms
23
Carcinoma, Non-Small-Cell Lung
22
Triple Negative Breast Neoplasms
15
Pancreatic Neoplasms
13
Breast Neoplasms, Male
11
Lung Neoplasms
10
Brenner Tumor
10
Inflammatory Breast Neoplasms
7
Uterine Cervical Neoplasms
5
Endometrial Adenocarcinoma
5
Adenocarcinoma of Lung
5
Urinary Bladder Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Melanoma
4
Cholangiocarcinoma
4
Carcinoma, Ovarian Epithelial
4
Adenocarcinoma, Bronchiolo-Alveolar
4
Adenocarcinoma Of Esophagus
4
Pleural Effusion, Malignant
3
Pancreatic Adenocarcinoma
3
Neoplasms
3
Thymoma
2
Neurotoxicity Syndromes
2
Gallbladder Neoplasms
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Carcinosarcoma
2
Breast Carcinoma In Situ
2
Interventions
mogamulizumab
3
Cyclophosphamide
3
Lenalidomide
2
Alemtuzumab
2
ruxolitinib
1
peginterferon alfa-2b
1
fludarabine phosphate
1
fludarabine
1
etoposide phosphate
1
denileukin diftitox
1
belinostat
1
Zidovudine
1
Vincristine
1
Raltegravir Potassium
1
Prednisone
1
Oxaliplatin
1
Introns
1
Interleukin-15
1
Gemcitabine
1
Etoposide
1
Doxorubicin
1
Dexamethasone
1
Daclizumab
1
Cytarabine
1
Cisplatin
1
Calcium Dobesilate
1
Bortezomib
1
B3(Fv)-PE38KDEL recombinant immunotoxin
1
10-propargyl-10-deazaaminopterin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia-Lymphoma, Adult T-Cell
×
Taxes
×
Clear all
No trials found.